

NVIDIA Top Inception Showcase 2026 — one of ten life-science startups selected
Accelerating Drug Discovery with AI
Chaparral Discovery
The AI platform for drug discovery
Turn proteomics and multi-omics data into therapeutic targets, biomarkers, and actionable insights.
Currently available for early partnerships and enterprise evaluation. Reach out through the Contact page to learn more.
In the press: San Diego Business Journal — “Chaparral Labs using AI to find better drug targets” →
Used by researchers at












What We Do
Chaparral Discovery
One platform that turns proteomics and multi-omics data into actionable drug discovery insights.
Chaparral Discovery
A unified drug discovery environment that integrates reprocessed omics data, public databases, scientific literature, and a knowledge graph into one AI-powered platform.
Target & Biomarker Discovery
Apply established AI and machine learning methods to proteomics, metabolomics, and multi-omics data to identify therapeutic targets and biomarkers.
Evidence-Backed Insights
Every result is traceable to reprocessed data, public databases, or literature — giving drug discovery teams confidence in every hypothesis.

Engine for the Platform
A Bioinformatics Foundation for AI
Garbage in, garbage out. Chaparral Discovery is built on a rigorous bioinformatics foundation of deep, accurate proteomics data analysis — the bedrock every AI model needs to deliver trustworthy discovery insights.
Deep Proteome Coverage
Rigorous data acquisition analysis that captures deep, accurate proteome coverage.
Targeted Quantification
Precise, targeted quantitative analysis for reliable, reproducible measurements.
Scalable Data Processing
Machine learning-driven analysis pipelines built for scalable proteomics data.
From Data to Discovery
How the Platform Works
Quality-Controlled Data
Proteomics, metabolomics, and multi-omics data are processed through rigorous bioinformatics engines to ensure accuracy and reproducibility.
Knowledge Graph
Entities, relationships, and evidence are structured in a Neo4j knowledge graph connecting proteins, pathways, diseases, drugs, and literature.
AI-Powered Insights
Predictive modeling, target prioritization, and drug repositioning analysis identify high-confidence targets and biomarkers.
Actionable Discovery
Evidence-backed hypotheses feed into therapeutic programs, partnered research, and enterprise evaluation workflows.
See Chaparral Discovery in Action
Tell us about your discovery challenge. We'll schedule a call to show you how the platform works for your research.